Kefdensis
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Kefdensis, covering 2026-03-04 to 2026-07-17. Get the full timeline:
Most recent: EMA Authorised: Kefdensis (denosumab) — Stada Arzneimittel AG
3 regulatory and trial events tracked for Kefdensis, covering 2026-03-04 to 2026-07-17. Get the full timeline:
Most recent: EMA Authorised: Kefdensis (denosumab) — Stada Arzneimittel AG